UCSF received $815 million in awards from the National Institutes of Health (NIH) last year for research that will improve the lives of patients in the U.S. and around the world.

A paralyzed man was able to move a robotic arm and fingers simply by imagining himself doing so, with the help of brain signals decoded through a computer.

Tuberculosis has stalked humanity for as nearly as long as we've been on earth. In this article, we take a look at how UCSF is leading the fight against the leading infectious disease killer.

A Q&A w/Alison Cohen, PhD, MPH, who is among the estimated 5% of the population with Long COVID. She talks through the implications of Long COVID, and how she applies her scientific and personal experience to research this debilitating condition.

Three new construction cranes have arrived at UCSF's Parnassus Heights campus, marking a major milestone in the construction of the new UCSF Health Helen Diller Hospital and UCSF Barbara and Gerson Bakar Research and Academic Building. The cranes will be used to lift materials and equipment for the new buildings, which are scheduled to open in 2028 and 2030, respectively.

How did humans evolve brains capable of complex language, civilization, and more? Scientists at UC San Francisco recently found that parts of our chromosomes have evolved at breakneck speeds to give us an edge in brain development compared to apes.

A new UCSF study shows that the human lungs have just as many blood-producing stem cells as bone marrow. These stem cells are a precious resource for a variety of therapies for conditions like leukemia or lung diseases.

COPA syndrome causes lung hemorrhaging starting in childhood. But one in three people with the disease mutation are spared. UCSF scientists have discovered how a separate gene variant protects those relatives – lighting the way to a possible cure.

Martin Kampmann, PhD, and Anna Victoria Molofsky, MD, PhD, are the 2025 recipients of the Bowes Biomedical Investigator award, which supports scientists who take novel approaches and have the potential to make significant contributions to biomedicine. Recipients receive $1.25 million over five years.